Express Scripts Sees Opportunity For 75% Generic Fill Rate
This article was originally published in The Pink Sheet Daily
Executive Summary
Maximizing the generic fill rate for gastrointestinal and lipid lowering drugs could amount to $10 bil. in savings from the commercially insured population alone, VP Miller says.
You may also be interested in...
Express Scripts Says Customers Support Removal Of Several Pfizer Products From Formulary
Decision to drop Lipitor and Norvasc from its 2006 formulary represents an opportunity for savings without compromising health outcomes, the PBM says.
Future BIO Global Efforts Include International Relations, Greenwood Says
HAMBURG, Germany - Due to the increasingly global nature of biotechnology, the Biotechnology Industry Organization's board of directors will meet next month to discuss a proposal to expand its global reach and potentially create a department of international relations, BIO President Jim Greenwood said Nov. 13
Hospira’s Mayne Event: Acquisition Strengthens Oncology Portfolio
Merger will create the leading generic injectable pharmaceutical company in the world.